Clinical Trial Update: Growth Factor/Insulin-like Growth Factor (GH/IGF)-1 Axis in Obese Subjects in Treatment With Orlistat

View source ↗

Summary

Completed clinical trial examining the GH/IGF-1 axis in obese subjects treated with the weight-loss drug orlistat.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Orlistat (orlistat)

Snippet

Sponsor: Federico II University | Conditions: Obesity | Status: COMPLETED